These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status]. Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF. Zhonghua Zhong Liu Za Zhi; 2018 Mar 23; 40(3):232-238. PubMed ID: 29575846 [Abstract] [Full Text] [Related]
3. Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia. Chang YJ, Chen HC, Lee BH, You SL, Lin CY, Pan MH, Chou YC, Hsieh CY, Chen YM, Cheng YJ, Chen CJ, CBCSP-HPV Study Group. Int J Cancer; 2011 Aug 15; 129(4):965-73. PubMed ID: 20949622 [Abstract] [Full Text] [Related]
4. Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18. Fu Xi L, Schiffman M, Ke Y, Hughes JP, Galloway DA, He Z, Hulbert A, Winer RL, Koutsky LA, Kiviat NB. Int J Cancer; 2017 Apr 15; 140(8):1747-1756. PubMed ID: 28052328 [Abstract] [Full Text] [Related]
5. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population. Zhao XL, Hu SY, Zhang Q, Dong L, Feng RM, Han R, Zhao FH. J Gynecol Oncol; 2017 Jul 15; 28(4):e30. PubMed ID: 28541628 [Abstract] [Full Text] [Related]
6. Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3. Xi LF, Schiffman M, Hughes JP, Galloway DA, Koutsky LA, Kiviat NB. Cancer Epidemiol Biomarkers Prev; 2019 Aug 15; 28(8):1388-1394. PubMed ID: 31101617 [Abstract] [Full Text] [Related]
7. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway. Vintermyr OK, Iversen O, Thoresen S, Quint W, Molijn A, de Souza S, Rosillon D, Holl K. Gynecol Oncol; 2014 May 15; 133(2):159-66. PubMed ID: 24631451 [Abstract] [Full Text] [Related]
8. Human papillomavirus genotype in cervical intraepithelial neoplasia grades 2 and 3 of Taiwanese women. Chao A, Jao MS, Huang CC, Huang HJ, Cheng HH, Yang JE, Hsueh S, Chen TC, Qiu JT, Lin CT, Fu CJ, Chou HH, Lai CH. Int J Cancer; 2011 Feb 01; 128(3):653-9. PubMed ID: 20473874 [Abstract] [Full Text] [Related]
9. The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China. Zhang J, Zhang D, Yang Z, Wang X, Wang D. BMC Cancer; 2020 May 19; 20(1):443. PubMed ID: 32429919 [Abstract] [Full Text] [Related]
10. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases. Tao X, Zhang H, Zhang H, Xiao Y, Zhong F, Zhou X, Cong Q, Sui L, Zhao C. Cancer Cytopathol; 2022 Jul 19; 130(7):542-550. PubMed ID: 35312217 [Abstract] [Full Text] [Related]
11. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. Coutlée F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL. J Med Virol; 2011 Jun 19; 83(6):1034-41. PubMed ID: 21503917 [Abstract] [Full Text] [Related]
12. Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework. Xu L, Padalko E, Oštrbenk A, Poljak M, Arbyn M. Int J Mol Sci; 2018 Sep 11; 19(9):. PubMed ID: 30208597 [Abstract] [Full Text] [Related]
14. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3. Wentzensen N, Sun C, Ghosh A, Kinney W, Mirabello L, Wacholder S, Shaber R, LaMere B, Clarke M, Lorincz AT, Castle PE, Schiffman M, Burk RD. J Natl Cancer Inst; 2012 Nov 21; 104(22):1738-49. PubMed ID: 23093560 [Abstract] [Full Text] [Related]
15. HPV genotype distribution according to severity of cervical neoplasia. Sjoeborg KD, Tropé A, Lie AK, Jonassen CM, Steinbakk M, Hansen M, Jacobsen MB, Cuschieri K, Eskild A. Gynecol Oncol; 2010 Jul 21; 118(1):29-34. PubMed ID: 20406711 [Abstract] [Full Text] [Related]
16. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. Kjær SK, Frederiksen K, Munk C, Iftner T. J Natl Cancer Inst; 2010 Oct 06; 102(19):1478-88. PubMed ID: 20841605 [Abstract] [Full Text] [Related]
17. Human papillomavirus DNA integration and messenger RNA transcription in cervical low- and high-risk squamous intraepithelial lesions in Austrian women. Manavi M, Hudelist G, Fink-Retter A, Gschwantler-Kaulich D, Pischinger K, Czerwenka K. Int J Gynecol Cancer; 2008 Oct 06; 18(2):285-94. PubMed ID: 17587315 [Abstract] [Full Text] [Related]
18. Variant-specific persistence of infections with human papillomavirus Types 31, 33, 45, 56 and 58 and risk of cervical intraepithelial neoplasia. Xi LF, Schiffman M, Koutsky LA, Hughes JP, Hulbert A, Shen Z, Galloway DA, Kiviat NB. Int J Cancer; 2016 Sep 01; 139(5):1098-105. PubMed ID: 27121353 [Abstract] [Full Text] [Related]
19. HPV-genotypes in high-grade intraepithelial cervical lesions in Danish women. Kirschner B, Schledermann D, Holl K, Rosenlund M, Raillard A, Quint W, Molijn A, Jenkins D, Junge J. Acta Obstet Gynecol Scand; 2013 Sep 01; 92(9):1032-40. PubMed ID: 23647074 [Abstract] [Full Text] [Related]
20. Distribution of human papillomavirus 58 and 52 E6/E7 variants in cervical neoplasia in Chinese women. Ding T, Wang X, Ye F, Cheng X, Ma D, Lu W, Xie X. Gynecol Oncol; 2010 Dec 01; 119(3):436-43. PubMed ID: 20870281 [Abstract] [Full Text] [Related] Page: [Next] [New Search]